Quest Diagnostics Stock Price - DGX

116.76
-2.77 (-2.32%)
Upgrade to Real-Time
Regular Market
116.76
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Quest Diagnostics Inc DGX NYSE Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-2.77 -2.32% 116.76 116.75 120.645 120.45 119.53 15:46:36
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
18,948 1,194,362 $ 118.10 $ 141,050,342 2,057,370 73.01 - 126.00
Last Trade Time Type Quantity Stock Price Currency
15:46:36 100 $ 116.76 USD

Quest Diagnostics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 15.75B 133.73M 132.05M $ 7.73B $ 843.68M 6.28 20.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
4.65M $ 1.59 1.35% 28.00 1.30%

more financials information »

Quest Diagnostics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical DGX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week118.78123.87115.43119.581,800,924-2.02-1.7%
1 Month108.87123.87104.49114.371,572,4747.897.25%
3 Months97.56126.0073.0197.262,121,48319.2019.68%
6 Months106.41126.0073.01101.111,575,44210.359.73%
1 Year98.11126.0073.01101.651,228,19718.6519.01%
3 Years109.81126.0073.0199.241,057,7836.956.33%
5 Years74.68126.0059.65591.671,010,29442.0856.35%

Quest Diagnostics Description

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of 2,000 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.


Your Recent History
NYSE
DGX
Quest Diag..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.